Drug Delivery with Targeted Nanoparticles

NOTE EDITORE

Nanotechnology has the potential to change every part of our lives. Today, nanotechnology-based products are used in many areas, and one of the most important areas is drug delivery. Nanoparticulate drug delivery systems not only provide controlled delivery of drugs and improved drug solubility but also improve drug efficiency and reduce side effects via targeting mechanisms. However, compared with conventional drug delivery systems, few nanoparticle-based products are on the market and almost all are nontargeted or only passively targeted systems. In addition, obtaining targeted nanoparticle systems is quite complex and requires several evaluation mechanisms. This book discusses the production, characterization, regulation, and currently marketed targeted nanoparticle systems in a broad framework. It provides an overview of targeted nanoparticles’ (i) in vitro characterization, such as particle size, stability, ligand density, and type; (ii) in vivo behavior for different targeting areas, such as tumor, brain, and vagina; and (iii) current advances in this field, including clinical trials and regulation processes.

SOMMARIO

1. Particle Size Determination of Targeted Nanoparticles 2. Zeta Potential Determination of Targeted Nanoparticles 3. Stability of Targeted Nanoparticles 4. Impact of PEGylation on Targeted Nanoparticulate Delivery 5. Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent Updates and Challenges 6. Characterization of Biological Molecule–Loaded Nanostructures Using Circular Dichroism and Fourier Transform Infrared Spectroscopy 7. Evaluation of Stimuli-Sensitive Nanoparticles in vitro 8. Analytical Techniques for Characterization of Nanodrugs 9. Cytotoxicity and Biological Compatibility 10. Cellular Uptake and Transcytosis 11. Evaluation of 3D Cell Culture Models for Efficacy Determination of Anticancer Nanotherapeutics 12. In vitro and in vivo Blood–Brain Barrier Models for the Evaluation of Drug Transport with Targeted Nanoparticles 13. Sterility Evaluation of Targeted Nanoparticles 14. Evaluation of Pharmacokinetics and Biodistribution of Targeted Nanoparticles 15. Evaluation of the in vivo Preclinical Toxicity of Targeted Nanoparticles 16. Transdermal Delivery of Targeted Nanoparticles and in vitro Evaluation 17. In vivo and in vitro Evaluation of Nose-to-Brain Delivery of Nanoparticles 18. Evaluation of Targeted Nanoparticles for Ocular Delivery 19. Vaginally Applied Nanocarriers and Their Characterizations 20. Oral Administration of Nanoparticles and Approaches for Design, Evaluation, and State of the Art 21. Drug Resistance Mechanisms and Strategies to Overcome Drug Resistance with Nanoparticulate Systems 22. Clinical Trials of Targeted Nanoparticulate Drug Delivery Systems 23. Evaluation of Targeted Mesoporous Silica Nanoparticles 24. Evaluation of Targeted Liposomes 25. Prospects of Nanomedicine with Nanocrystal Technology 26. Characteristics of Marketed Nanopharmaceutics 27. Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines

AUTORE

Yilmaz Çapan is Professor and Head of the Pharmaceutical Technology Department, Faculty of Pharmacy, Hacettepe University, Turkey. He obtained his bachelor’s degree in pharmacy from Hacettepe University in 1972 and PhD with honors from the University of Lille, Faculty of Pharmacy, France, in 1978. He has authored more than 80 publications in prestigious, refereed pharmaceutical science journals, with a current citation number of more than 2000, and 3 books. Prof. Çapan is a member of the American Association of Pharmaceutical Scientists, the Association of Pharmaceutical Sciences of Ankara, the Turkish Pharmacists’ Association, and the Pharmacist’s Chamber of Ankara. His research interests include tabletting sustainedrelease oral solid dosage forms, bioadhesion, protein delivery from biodegradable microspheres, and brain drug targeting. Adem Sahin is Assistant Professor at the Faculty of Pharmacy, Selçuk University, Turkey. He obtained his bachelor’s degree in pharmacy from Erciyes University, Turkey, in 2011 and PhD with honors from the Department of Pharmaceutical Technology, Hacettepe University, in 2017. He has been working in the pharmaceutical industry as a formulation specialist and a clinical trials executive and his research interests include brain drug delivery, cancer nanomedicine, and nanotechnology in drug delivery. Hayrettin Tonbul is Assistant Professor at the Faculty of Pharmacy, Inönü University, Turkey. He obtained his bachelor’s degree in pharmacy from Near East University, Turkey, in 2015 and PhD with honors from the Department of Pharmaceutical Technology, Hacettepe University, in 2019. His research interests include controlled and targeted drug delivery, cancer nanomedicine, and nanotechnology in drug delivery.

ALTRE INFORMAZIONI

• Condizione: Nuovo
• ISBN: 9789814877756
• Dimensioni: 9 x 6 in Ø 3.57 lb
• Formato: Copertina rigida
• Illustration Notes: 17 b/w images, 48 color images, 31 tables, 5 color halftones, 17 line drawings and 43 color line drawings
• Pagine Arabe: 762
• Pagine Romane: xxviii